| Studien - Rekrutierungsende |
|
|
 |
| AUO Nr.: AP 38/03 Prostata |
Details
zur Studie |
| Titel: | Effectiveness of Zometa® treatment for the prevention of bone metastases in high risk prostate cancer patients. A randomized, open-label, multicenter study of the European Association of Urology (EAU) in Cooperation with the Scandinavian Prostate Cancer |
| Studienleiter: | Herr Prof. Dr. Kurt Miller - Charité-Universitätsmedizin Berlin Campus Benjamin Franklin 12200 Berlin Hindenburgdamm 30 Tel:030/8445-25 75 kurt.miller@charite.de |
|
| AUO Nr.: AP 49/07 Prostata |
Details
zur Studie |
| Titel: | Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer (VENICE) |
| Studienleiter: | Herr Prof. Dr. med. Peter Albers - Heinrich-Heine-Universität Düsseldorf 40225 Düsseldorf Moorenstr. 5 Tel:0211/81 18-110 sekrurol@uni-duesseldorf.de |
|
| AUO Nr.: AP 50/08 Prostata |
Details
zur Studie |
| Titel: | Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy |
| Studienleiter: | Herr Prof. Dr. Michael Stöckle - Universitätskliniken des Saarlandes 66421 Homburg/Saar Kirrberger Str. Tel:06841/16 24 700 urmsto@uniklinik-saarland.de |
|
| AUO Nr.: AP 53/08 Prostata |
Details
zur Studie |
| Titel: | A Phase III, Randomised, Double-blind Study to Assess the Efficacy and Safety of 10 mg ZD 4054 versus Placebo in Patients with Hormone-resistant Prostate Cancer and Bone Metastasis who are Pain Free or Mildly Symptomatic |
| Studienleiter: | Herr PD Dr. med. Maurice Stephan Michel - Universitätsklinikum Mannheim 68135 Mannheim Theodor-Kutzer-Ufer 1-3 Tel:0621/383-22 35 maurice-stephan.michel@uro.ma.uni-heidelberg.de |
|
| AUO Nr.: AP 54/09 Prostata |
Details
zur Studie |
| Titel: | A Phase 3, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate (CB7630) Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients with Metastatic Castration-Resistant Prostate Cancer |
| Studienleiter: | Herr Prof. Dr. med. Peter Albers - Heinrich-Heine-Universität Düsseldorf 40225 Düsseldorf Moorenstr. 5 Tel:0211/81 18-110 sekrurol@uni-duesseldorf.de |
| ../images/log2.gif |
| AUO Nr.: AB 33/07 Blase |
Details
zur Studie |
| Titel: | A Phase II Study of AZD4877 (a Novel Anti-Mitotic Agent) in Advanced Bladder Cancer |
| Studienleiter: | Herr Prof. Dr. med. Peter Albers - Heinrich-Heine-Universität Düsseldorf 40225 Düsseldorf Moorenstr. 5 Tel:0211/81 18-110 sekrurol@uni-duesseldorf.de |
|
| AUO Nr.: AN 24/07 Niere |
Details
zur Studie |
| Titel: | Phase 2, randomized, open label, multicenter study of intradermal IMA901 plus GM-CSF with or without low dose cyclophosphamide pre-treatment in advanced renal cell carcinoma patients with measurable disease |
| Studienleiter: | Frau Dr. Alexandra Kirner - Tel: kirner@immatics.com |